FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808676167> ?p ?o ?g. }

• W2808676167 endingPage "e416" @default.
• W2808676167 startingPage "e409" @default.
• W2808676167 abstract "Objectives: Clonidine is an antihypertensive drug used for analgosedation in the PICU. Lack of reliable data on its hemodynamic tolerance limits its use. This study explores the hemodynamic tolerance of IV clonidine infusion in a broad population of children with high severity of disease. Design: Retrospective analysis of prospectively collected data. Setting: A tertiary and quaternary referral PICU. Patients: Critically ill children age 0–18 years old who received an IV clonidine infusion for analgosedation of at least 1 hour. Interventions: None. Measurements and Main Results: The primary endpoints were the prevalences of bradycardia and hypotension. Secondary endpoints were changes in heart rate, blood pressure, Vasoactive-Inotropic Score, COMFORT Behavior score (a sedation scoring scale), and body temperature during the infusion. The association of bradycardia with other hemodynamic variables was explored, as well as potential risk factors for severe bradycardia. One-hundred eighty-six children (median age, 12.9 mo [interquartile range, 3.5–60.6 mo]) receiving a maximum median clonidine infusion of 0.7 µg/kg/hr (interquartile range, 0.3–1.5) were included. Severe bradycardia and systolic hypotension occurred in 72 patients (40.2%) and 105 patients (58%), respectively. Clonidine-associated bradycardia was hemodynamically well tolerated, as it was not related with hypotension and the need for vasoactive drugs decreased in parallel with a sedation score guided clonidine infusion rate increase. Younger age was the only identified risk factor for clonidine-associated bradycardia. Conclusions: Although administration of clonidine is often associated with bradycardia and hypotension, these complications do not seem clinically significant in a mixed PICU population with a high degree of disease severity. Clonidine may have a vasoactive-inotropic sparing effect." @default.
• W2808676167 created "2018-06-21" @default.
• W2808676167 creator A5026235423 @default.
• W2808676167 creator A5043853734 @default.
• W2808676167 creator A5074206527 @default.
• W2808676167 creator A5079326760 @default.
• W2808676167 date "2018-08-01" @default.
• W2808676167 modified "2023-10-06" @default.
• W2808676167 title "Hemodynamic Tolerance to IV Clonidine Infusion in the PICU*" @default.
• W2808676167 cites W1627338445 @default.
• W2808676167 cites W1896475345 @default.
• W2808676167 cites W1963656740 @default.
• W2808676167 cites W2011293979 @default.
• W2808676167 cites W2020306979 @default.
• W2808676167 cites W2023046309 @default.
• W2808676167 cites W2025202822 @default.
• W2808676167 cites W2027308059 @default.
• W2808676167 cites W2059382284 @default.
• W2808676167 cites W2060910799 @default.
• W2808676167 cites W2064723894 @default.
• W2808676167 cites W2065653458 @default.
• W2808676167 cites W2068269421 @default.
• W2808676167 cites W2074070892 @default.
• W2808676167 cites W2077419952 @default.
• W2808676167 cites W2078305064 @default.
• W2808676167 cites W2082770252 @default.
• W2808676167 cites W2086375833 @default.
• W2808676167 cites W2089335936 @default.
• W2808676167 cites W2092958052 @default.
• W2808676167 cites W2101041114 @default.
• W2808676167 cites W2111713064 @default.
• W2808676167 cites W2119494065 @default.
• W2808676167 cites W2130124185 @default.
• W2808676167 cites W2133314444 @default.
• W2808676167 cites W2133410671 @default.
• W2808676167 cites W2135824220 @default.
• W2808676167 cites W2152960573 @default.
• W2808676167 cites W2163363744 @default.
• W2808676167 cites W2191753595 @default.
• W2808676167 cites W2321829810 @default.
• W2808676167 cites W2326415736 @default.
• W2808676167 cites W2328653397 @default.
• W2808676167 cites W2413702030 @default.
• W2808676167 cites W2414484093 @default.
• W2808676167 cites W2743554877 @default.
• W2808676167 cites W4205271551 @default.
• W2808676167 cites W4238640241 @default.
• W2808676167 doi "https://doi.org/10.1097/pcc.0000000000001602" @default.
• W2808676167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29912068" @default.
• W2808676167 hasPublicationYear "2018" @default.
• W2808676167 type Work @default.
• W2808676167 sameAs 2808676167 @default.
• W2808676167 citedByCount "13" @default.
• W2808676167 countsByYear W28086761672018 @default.
• W2808676167 countsByYear W28086761672019 @default.
• W2808676167 countsByYear W28086761672020 @default.
• W2808676167 countsByYear W28086761672021 @default.
• W2808676167 countsByYear W28086761672022 @default.
• W2808676167 countsByYear W28086761672023 @default.
• W2808676167 crossrefType "journal-article" @default.
• W2808676167 hasAuthorship W2808676167A5026235423 @default.
• W2808676167 hasAuthorship W2808676167A5043853734 @default.
• W2808676167 hasAuthorship W2808676167A5074206527 @default.
• W2808676167 hasAuthorship W2808676167A5079326760 @default.
• W2808676167 hasConcept C119060515 @default.
• W2808676167 hasConcept C126322002 @default.
• W2808676167 hasConcept C178853913 @default.
• W2808676167 hasConcept C2776452961 @default.
• W2808676167 hasConcept C2776814716 @default.
• W2808676167 hasConcept C2777495988 @default.
• W2808676167 hasConcept C2777953023 @default.
• W2808676167 hasConcept C2778399450 @default.
• W2808676167 hasConcept C42219234 @default.
• W2808676167 hasConcept C71924100 @default.
• W2808676167 hasConcept C84393581 @default.
• W2808676167 hasConceptScore W2808676167C119060515 @default.
• W2808676167 hasConceptScore W2808676167C126322002 @default.
• W2808676167 hasConceptScore W2808676167C178853913 @default.
• W2808676167 hasConceptScore W2808676167C2776452961 @default.
• W2808676167 hasConceptScore W2808676167C2776814716 @default.
• W2808676167 hasConceptScore W2808676167C2777495988 @default.
• W2808676167 hasConceptScore W2808676167C2777953023 @default.
• W2808676167 hasConceptScore W2808676167C2778399450 @default.
• W2808676167 hasConceptScore W2808676167C42219234 @default.
• W2808676167 hasConceptScore W2808676167C71924100 @default.
• W2808676167 hasConceptScore W2808676167C84393581 @default.
• W2808676167 hasIssue "8" @default.
• W2808676167 hasLocation W28086761671 @default.
• W2808676167 hasLocation W28086761672 @default.
• W2808676167 hasOpenAccess W2808676167 @default.
• W2808676167 hasPrimaryLocation W28086761671 @default.
• W2808676167 hasRelatedWork W1987658202 @default.
• W2808676167 hasRelatedWork W2004963932 @default.
• W2808676167 hasRelatedWork W2103714861 @default.
• W2808676167 hasRelatedWork W2118303527 @default.
• W2808676167 hasRelatedWork W2359780091 @default.
• W2808676167 hasRelatedWork W2979617965 @default.
• W2808676167 hasRelatedWork W3153296609 @default.

• next